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Abstract  
The search for natural products with benefits for health in general and of potential for treating human disease has 
gained wider interest world-wide. Here, we analyse current data on the microalga Arthrospira platensis (AP), that 
has been used in nutrition since ancient times in Fare East and African communities, for medical purposes with a 
focus on dermatology. Extracts of AP have been investigated in vitro and in vivo. The alga is rich in proteins, 
lipopolysaccharides and gamma-linolenic acid. AP extracts, phycocyanin compounds and polysaccharide calcium 
spirulan (Ca-SP) have been evaluated in various models. It could be demonstrated, that AP has significant 
antioxidant activity, prevents viruses from entry into target cells and inhibits the colonisation of wounds by multi-
resistant bacteria. Furthermore, anti-cancer activity was documented in models of oral cancer, melanoma, and 
UV-induced non-melanoma skin cancer. 
 
 
 
 
 
 
 
 
Introduction 
 
Arthrospira (formerly: Spirulina) platensis (AP) 
is one of the photoautotrophic, planktonic, filamentous 
green-blue algae that have become of medical 
interest. It has been used as a protein-rich nutrient 
since ancient times for instance by the Kanem in 
Tchad, in Japan and Korea. Seventy percent of dry 
matter of AP is proteins [1]. The water-soluble fraction 
of proteins contains molecules between 11,000 and > 
300,000 kDa [2]. This plant is very rich in gamma-
linolenic acid (GLA) which is produced by the alga by 
direct desaturation of linoleic acid [1][3][4]. AP also 
has a high content of vitamin B complex, carotene, 
and ascorbic acid [5].  
The whole cells of AP and 
lipopolysaccharides isolated from these cells are 
immunomodulatory in rabbits leading to the production 
of macro - and microglobulin antibodies [6]. 
In this review, we focus on medical indications 
for the possible use of AP in dermatology. 
 
 
Antiviral activities 
 
An aqueous extract of AP containing 
lipopolysaccharides as well as a fraction depleted of 
polysaccharides and tannins inhibited HIV - 1 
replication in human T - cell lines, peripheral blood 
mononuclear cells (PBMC), and Langerhans cells 
(LC). The 50% inhibitory concentration (IC50) of 
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extract for PBMC growth ranged between 0.8 and 3.1 
mg/ml. In vitro, the extract inactivated HIV - 1 directly, 
i.e. viral entry and fusion [7].  
In a small phase I trial, five HIV - infected, 
treatment naïve adult patients took algae extracts 
from either AP or brown seaweed Undaria pinnatifida 
or a mixture of both for 3 to 13 months. No toxicities 
were observed, but a bB stabilisation of the CD4 cell 
count and virus load was found. Both parameters 
improved after 13 months [8]. 
Allophycocyanin from AP neutralised in vitro 
the enterovirus 71 - induced cytopathic effects in both 
human rhabdomyosarcoma cells and African green 
monkey kidney cells with an IC50 of approximately 
0.045 ± 0.012 µM. Allophycocyanin was active in the 
state of viral adsorption and post-adsorption, 
respectively. However, the antiviral activity was 
superior when added to the cell cultures before viral 
infection. Allophycocyanin delayed the viral RNA 
synthesis in infected cells and reduced thereby 
enterovirus - 71 - induced apoptosis [8]. 
Aqueous extracts of AP and purified calcium 
spirulan (Ca-SP) were investigated for their potential 
in human herpes simplex virus 1(HHV1) and 8 (HHV8) 
infections. Ca-SP represents a sulfated 
polysaccharide mainly composed of rhamnose, that is 
capable of chelating calcium. In vitro, Ca-SP inhibited 
HHV1 infection of Vero cells with an IC50 of 0.04 
µg/mL and HaCaT cells with an IC50 of 0.07 µg/mL. 
AP extract was lesser effective. Ca - SP inhibited the 
delivery of viral protein VP16, that is necessary for 
viral attachment to target cells, in a dose-dependent 
manner. In an observational trial, 198 adult female 
patients, who underwent a procedure for permanent 
lip makeup and had a history of previous herpes 
labialis, were included. Patients received herpes 
prophylaxis with either topical ointment containing AP 
extract and Ca - SP, topical acyclovir or systemic 
acyclovir/ valacyclovir. Herpes reactivation was 
observed in about 20% with systemic medications, 
90% with topical acyclovir, and 60% with topical AP 
extract/ Ca-SP [10]. In conclusion, topical AP extract/ 
Ca - SP was more effective in this open trial than 
topical acyclovir. 
HHV8 is responsible for cutaneous Kaposi 
sarcoma. Tissue cultures of human RPE - 1 cells were 
infected by HHV8. The IC50 for Ca-SP for HHV8 titer 
reduction and reduction of DNA copies in treated 
versus untreated controls was 1.5µg/mL. Ca - SP 
inhibited the uptake of viral ORF45 tegument protein 
by target cells in a dose-dependent manner [10].  
 
 
Antioxidant activity 
 
It was shown that a protean extract of AP is a 
potent free-radical scavenger for both hydroxyl and 
peroxyl radicals and inhibits microsomal lipid 
peroxidation. The major component of this activity is 
the phycobiliprotein C - phycocyanin [11]. 
C - phycocyanin has been evaluated in 
several models of inflammation. It was shown to 
reduce oedema, histamine release from mast cells, 
myeloperoxidase activity of macrophages, and the 
concentrations of prostaglandin-E2 and leukotriene 
LTB4 in inflammatory lesions [12].  
Chinese researchers succeeded in the 
crystallisation of the selenium-containing phycocyanin 
from the selenium-rich by the hanging-drop vapour 
diffusion techniques [13]. Indian researchers 
developed a method of purification of C - phycocyanin 
[14]. 
Experimental studies have been performed to 
analyse the potential of AP as a matrix for the 
production of selenium - and iodine-containing 
pharmaceuticals [15]. 
More recently, the potential of algae extracts 
on diabetic nephropathy was investigated in a mouse 
model. Oral administration of phycocyanin (300 
mg/kg) for ten weeks protected against albuminuria 
and renal mesangial expansion. The compound also 
normalised tumour growth factor-β and fibronectin 
expression. Phycocyanin was capable of normalising 
urinary and renal oxidative stress markers and the 
expression of NAD(P)H oxidase components. Similar 
antioxidant effects were observed following oral 
administration of phycocyanobilin (15 mg/kg) for two 
weeks. Phycocyanobilin also inhibited NADPH 
dependent superoxide production in cultures of renal 
mesangial cells [16]. 
By the use of one-step high-speed counter-
current chromatography (HSCCC) with ethanol-
ammonium sulfate, another major antioxidant could be 
isolated: a α - acidic polysaccharide, composed of 
major glucose, slight rhamnose and mannose, with a 
molecular weight of 12.33 kDa [17]. 
Reactive oxygen species and mitochondrial 
dysfunction have been implicated in doxorubicin-
induced and tilmicosin-induced cardiotoxicity [18][19] 
and ciclosporin A-induced and cisplatin-induced 
nephrotoxicity [20][21]. In mice and rat models of 
these diseases, extracts from AP exhibited dose-
dependent cytoprotective activities. Concerning 
cardiomyocytes, C - pyocyanin has been identified as 
the most active compound to protect cells from 
mitochondrial dysfunction, lipid and protein 
peroxidation thereby diminishing apoptosis [22]. 
Liver injury by liver toxins like dibutyl 
nitrosamine precursors [23], carbon tetrachloride [24], 
lead acetate [25], deltamethrin [26], and drugs such 
as acetaminophen [27] or cisplatin [28] can be 
diminished by AP extracts. 
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Anti-inflammatory, anti-pyretic, and anti -
hyperalgesic effects 
 
C-phycocyanin is a selective inhibitor of 
cyclooxygenase - 2 (COX-2), that is upregulated 
during inflammation and induces apoptosis in 
macrophages [29][30]. In a carrageenan-induced 
thermal hyperalgesia animal model C - phycocyanin 
was investigated for anti-inflammatory and anti-
hyperalgesic effects. C - phycocyanin inhibited the 
overproduction of nitric oxide (NO) and prostaglandin 
E2 by suppression of inducible NO synthase and 
COX-2. Also, there was an attenuation of TNF -alfa 
formation and tissue infiltration by neutrophilic 
granulocytes [31]. 
Antipyretic activity of AP was demonstrated in 
Brewer's Yeast induced pyrexia in rats. The anti-
inflammatory potential had been evaluated in rat paw 
oedema induced by prostaglandin E2 injection. In both 
models, AP extract revealed dose-dependent efficacy 
[32]. 
 
 
Wound healing potential 
 
Using an in vitro model with cultivated human 
dermal fibroblast various extracts of AP have been 
screened for a wound healing promotion. Aqueous 
extracts stimulated both proliferation and migration of 
fibroblasts and enhanced the closure rate of wounds 
within 24 hours after treatment. Methanolic and 
ethanolic extracts supported fibroblast proliferation too 
but failed to support migration and wound closure. 
The plant extracts were further characterised: 
Cinnamic acid, narigenin, kaempferol, temsirolimus, 
phosphatidylserine isomeric derivatives and 
sulphoquinovosyl diacylglycerol supported 
proliferation. The authors concluded that AP might 
pose potential medical use to treat chronic wounds 
especially in diabetes mellitus patients [33]. 
Colonization of chronic wounds with bacteria 
including methicillin-resistant Staphylococcus aureus 
(MRSA) is an increasing health problem [34]. Of 
interest for wound treatment is the fact that topical 
Maresometrade mark containing lipids and all other 
components of microalgae in an encapsulated form, is 
capable of inhibiting dermal colonisation by several 
MRSA strains and by vancomycin-resistant strain 
MU50. In animal models, MRSA colonisation was 
reduced by 3 - 4 log units in comparison to controls 
[35]. 
Gunes et al. (2017) used an aqueous AP 
crude extract in a concentration of 1.125% in a skin 
cream. The formulation enhanced wound healing in 
HS2 keratinocyte cell cultures [36]. 
Anti-cancer potential 
 
The first published data on the possible anti-
cancer potential of AP extracts came from 
dimethylbenz(a)anthracene - induced squamous cell 
carcinomas (SCC) of hamster buccal pouch as a 
model of oral SCC. Phylogenies from algae extract 
induced complete response in 30% and partial 
response in 70% of animals treated twice weekly by 
intratumoral injections [37]. 
In a model investigating the early epithelial 
changes leading to oral SCC, buccal pouches of the 
Syrian hamsters were painted with 7, 12 -
dimethylbenz[a]anthracene. Supplementation of the 
diet with AP extracts diminished epithelial dysplasia 
during 14 weeks of this study [38] and 32 weeks in a 
long-term study [39]. In the latter study, the 
progression to SCC was reduced by AOP extracts as 
well. 
By using an in vitro model of invasion of 
tumour cells through reconstituted basement 
membrane (Matrigel)/fibronectin-coated filters, the 
potential of Ca-SP isolated from AP was evaluated. 
Ca-SP significantly inhibited the invasion of B16 - BL6 
melanoma, Colon 26 M3.1 carcinoma and HT - 1080 
fibrosarcoma cells. Ca - SP also inhibited migration of 
tumour cells on laminin but failed on fibronectin. This 
effect was accompanied by prevented adhesion of 
B16-BL6 melanoma cells to Matrigel and laminin but 
did not affect the adhesion to fibronectin. 
Experimental lung metastasis was significantly 
reduced by co-injection of B16-BL6 cells with Ca - SP. 
In B16-BL6 spontaneous lung metastasis model, 
several intra-venous injections 100 µg of Ca - SP 
diminished the tumours lung colonisation [40].  
Non-melanoma skin cancer is induced by 
ultraviolet (UV) light exposure, natural and artificial. 
UVB (280 - 320nm) irradiation of skin induces the 
formation of 8-oxo - 7,8-dihydroguanine (8 - oxoG) by 
UV-induced reactive oxygen species. Ogg1 gene 
encodes a repair enzyme that removes 8 - oxoG -
DNA. Ogg1 - knock out (KO) mice, missing the repair 
enzyme, have become an established model for UVB-
induced skin cancer [41]. In Ogg1 - KO mice fed with 
AP extracts, skin tumours developed about seven 
weeks later than in control animals without AP 
extracts. Furthermore, the number of tumours was 
lower in AP-treated animals, but the ratio of malignant 
versus benign skin tumours remained unaffected by 
AP. The authors could further demonstrate, that AP 
lead to a reduced acute UVB-induced inflammation 
(ear swelling and erythema). AP downregulated 
signalling proteins such as p38 mitogen-activated 
protein kinase, kinase/c-Jun N-terminal kinase, and 
extracellular signal-regulated kinase after UVB 
exposure in mice [42]. AP extracts from their anti-
inflammatory, and anti-oxidative potential may be 
beneficial in UV - induced skin cancer. However, 
studies in humans are warranted before conclusions. 
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 In conclusion, AP is a source of various, 
partially identified and purified compounds with 
potential health benefits and activities in the 
prevention or treatment of some human pathologies, 
ranging from infections to environmental disorders, 
chronic wounds and cancer. Despite the vast 
advantages in basic research and in in vitro and in 
vivo models of disease, human trials are sparse. A 
better standardization of natural products and 
randomized controlled trials in human disease are 
necessary before final conclusions. Nevertheless, the 
potential of natural products as AP should not be 
underestimated [43]. 
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